Add BrightSurf on Google Email

The Lancet


Pirfenidone reduces rate of lung decline in idiopathic pulmonary fibrosis, raising hope for many thousands of patents

Pirfenidone reduces lung function decline in idiopathic pulmonary fibrosis patients, showing a clinically meaningful benefit and favourable safety profile. The treatment has been approved for mild to moderate idiopathic pulmonary fibrosis in Europe and shows promise for the estimated 100,000 people affected across the continent.

SourceThe Lancet_DELETED·JournalThe Lancet·DateMay 13, 2011

Japan: Accounts from doctors of the tsunami disaster, including the positive effect of Twitter and the moving of 600 dialysis patients

Twitter played a vital role in getting medical assistance to patients affected by the tsunami, particularly those with pulmonary hypertension. Meanwhile, a team of doctors successfully transferred 600 dialysis patients from Iwaki to Niigata hospital within a short timeframe, providing them with life-sustaining care.

SourceThe Lancet_DELETED·JournalThe Lancet·DateMay 12, 2011

Comment with the Lancet series on health in Brazil

The Lancet series highlights Brazil's successes in healthcare, but also notes areas of concern such as high caesarean section rates and increasing obesity. The country's experience offers valuable lessons for addressing health inequities and implementing reforms to prioritize public health.

SourceThe Lancet_DELETED·JournalThe Lancet·DateMay 9, 2011

The way forward

Brazil's unique national health service has improved health outcomes, but socioeconomic disparities and regional inequalities remain. The authors emphasize the need for coordinated action among government, private sector, academia, and civil society to address these challenges and secure universal access to healthcare.

SourceThe Lancet_DELETED·JournalThe Lancet·DateMay 9, 2011

Pakistan prepares to abolish Ministry of Health

Pakistani public health experts express shock and dismay at the government's plan to abolish the Ministry of Health. The move is seen as a threat to national health functions and capacity, particularly in light of ongoing challenges such as polio eradication and inadequate healthcare infrastructure.

SourceThe Lancet_DELETED·JournalThe Lancet·DateMay 5, 2011

Study shows extended-release naltrexone can be used effectively in opioid addicts, but linked comment authors criticize FDA for having approved drug for this use

A new study found that extended-release naltrexone is an effective treatment for opioid dependence, with patients experiencing high rates of abstinence and reduced craving. However, critics argue that the FDA's approval of this drug was premature and failed to adequately investigate risks, such as post-treatment overdose.

SourceThe Lancet_DELETED·JournalThe Lancet·DateApr 27, 2011

Current long-term surveillance strategy for women treated for precancerous cervical lesions effective for preventing cervical cancer

A study of 435 women who underwent treatment for precancerous cervical lesions found that a three-cytological-smears post-treatment surveillance strategy is effective in identifying women at long-term risk of cervical cancer. By adding high-risk human papillomavirus (hrHPV) testing, the need for subsequent screens can be reduced.

SourceThe Lancet_DELETED·JournalThe Lancet·DateApr 27, 2011

UK's tuberculosis screening strategy for immigrants misses most imported cases of latent infection and unlikely to prevent the spread of disease

A study finds that the UK's current tuberculosis screening policy for immigrants is missing 70% of imported latent infections. Implementing a broader screening program could identify 92% of infected immigrants and reduce future cases of active tuberculosis while remaining cost-effective.

SourceThe Lancet_DELETED·JournalThe Lancet Infectious Diseases·DateApr 20, 2011

Study of European HIV-positive children shows that 1 in 8 experience triple-class virological failure by 5 years after starting antiretroviral treatment

A study of European HIV-positive children reveals that 12% develop triple-class virological failure by 5 years after starting antiretroviral treatment, compared to adults. The high failure rate underlines the need for strategies to promote optimum drug adherence in children and young people.

SourceThe Lancet_DELETED·JournalThe Lancet·DateApr 19, 2011

Taking blood from Fukushima radiation workers in order to prepare for future stem cell transplants in case they are accidently exposed to high doses of radiation

Experts recommend collecting peripheral blood stem cells from Fukushima radiation workers to prepare for potential future stem cell transplants. This technique has several advantages over allogeneic transplantation, including reducing the risk of graft-versus-host disease and immunosuppression.

SourceThe Lancet_DELETED·JournalThe Lancet·DateApr 14, 2011

NDM-1-positive multidrug-resistant bacteria found in public water supplies and urban effluent in New Delhi suggesting NDM-1 is widespread in the environment

The study found NDM-1-positive bacteria in drinking-water samples and seepage samples from urban New Delhi, highlighting the need for global action to limit the worldwide spread of NDM-1 producing bacteria. The gene was also detected in pathogenic species like Shigella boydii and Vibrio cholerae.

SourceThe Lancet_DELETED·JournalThe Lancet Infectious Diseases·DateApr 6, 2011

World's leading scientists join forces to set priority interventions to save 36 million lives from non-communicable diseases

The Lancet NCD Action Group and the NCD Alliance recommend five priority interventions: reducing tobacco use, lowering salt intake, improving diets, reducing hazardous alcohol intake, and increasing access to essential drugs. These actions aim to reduce NCD death rates by 2% per year, avoiding an estimated 36 million deaths over 10 years.

SourceThe Lancet_DELETED·JournalThe Lancet·DateApr 5, 2011

International 50-year mortality trends in children and young people reveal an inadequate response to the health problems and causes of death in adolescents, particularly young men

The Lancet study finds that death rates in young people are now higher than in children across most high- and low-income countries, with injury being a major cause of death in young men. The authors highlight the lack of interventions and resources to tackle contemporary health problems faced by young people.

SourceThe Lancet_DELETED·JournalThe Lancet·DateMar 28, 2011

Just 6 months of hormone therapy doubles survival chances when added to radiotherapy in patients with locally advanced prostate cancer

A new study found that combining 6 months of hormone therapy with radiotherapy significantly improved survival rates for men with locally advanced prostate cancer. The treatment reduced the risk of death from prostate cancer by half and deaths from any cause by a third compared to radiation alone.

SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateMar 24, 2011

European guidelines for HIV tropism testing

The European Consensus Group has developed guidelines for HIV tropism testing, which is required before starting maraviroc treatment. The guidelines recommend phenotypic enhanced sensitivity Trofile assay or V3 loop genotypic sequencing for drug-naive patients with toxic side-effects or poor tolerability.

SourceThe Lancet_DELETED·JournalThe Lancet Infectious Diseases·DateMar 21, 2011